Small Cell Carcinoma of the Rectum-An Unexpected Diagnosis: Current Treatment Options for a Rare and Aggressive Entity.

Authors

• Taylor M Evangelisti
• Rebecca M Platoff
• Polina Khrizman
• Jamin C Morrison
• Upasana Joneja
• Ashleigh A Allen
• Danica N Giugliano
• Michael E Kwiatt
• Steven J McClane

Publication/Presentation Date

12-1-2023

Abstract

Rectal small cell carcinoma is a rare and aggressive cancer subtype for which a consensus of optimal treatment has not yet been reached. This cancer presents a difficult surgical problem, and thus, the mainstay of treatment tends to mirror that of small cell carcinoma of the lung (chemotherapy, radiation therapy, and immune modulators). This brief report highlights current treatment options available for this rare and difficult entity. There is a significant need for large-center clinical trials and prospective studies to help determine the best treatment regimen to effectively care for patients with small cell carcinoma of the rectum.

Volume

89

Issue

12

First Page

6359

Last Page

6361

ISSN

1555-9823

Published In/Presented At

Evangelisti, T. M., Platoff, R. M., Khrizman, P., Morrison, J. C., Joneja, U., Allen, A. A., Giugliano, D. N., Kwiatt, M. E., & McClane, S. J. (2023). Small Cell Carcinoma of the Rectum-An Unexpected Diagnosis: Current Treatment Options for a Rare and Aggressive Entity. The American surgeon, 89(12), 6359–6361. https://doi.org/10.1177/00031348231175116

Disciplines

Medicine and Health Sciences

PubMedID

37203324

Department(s)

Department of Pathology and Laboratory Medicine

Document Type

Article